Michael McDermott MBChB , Mohammed N. Meah MBChB, PhD , Phyo Khaing MBChB , Kang-Ling Wang MD , Jennifer Ramsay MBChB , Gillian Scott PhD , Hannah Rickman MPH , Tom Burt , Ian McGowan , Timothy Fairbairn MBChB, PhD , Marise Bucukoglu , Russell Bull MBBChir , Adam Timmis MBChB, PhD , Edwin J.R. van Beek MD, PhD , Giles Roditi MBChB , Philip D. Adamson MBChB, PhD, MPH , Steff Lewis MSC, PhD , John Norrie MSc , Brian McKinstry MBChB, MD , Bruce Guthrie MBChB, PhD , David E. Newby MBChB, PhD
{"title":"SCOT-HEART 2 试验的原理和设计：预防心肌梗死的 CT 血管造影。","authors":"Michael McDermott MBChB , Mohammed N. Meah MBChB, PhD , Phyo Khaing MBChB , Kang-Ling Wang MD , Jennifer Ramsay MBChB , Gillian Scott PhD , Hannah Rickman MPH , Tom Burt , Ian McGowan , Timothy Fairbairn MBChB, PhD , Marise Bucukoglu , Russell Bull MBBChir , Adam Timmis MBChB, PhD , Edwin J.R. van Beek MD, PhD , Giles Roditi MBChB , Philip D. Adamson MBChB, PhD, MPH , Steff Lewis MSC, PhD , John Norrie MSc , Brian McKinstry MBChB, MD , Bruce Guthrie MBChB, PhD , David E. Newby MBChB, PhD","doi":"10.1016/j.jcmg.2024.05.016","DOIUrl":null,"url":null,"abstract":"<div><p>Coronary artery disease continues to be the leading cause of death globally. Identifying patients who are at risk of coronary artery disease remains a public health priority. At present, the focus of cardiovascular disease prevention relies heavily on probabilistic risk scoring despite no randomized controlled trials demonstrating their efficacy. The concept of using imaging to guide preventative therapy is not new, but has previously focused on indirect measures such as carotid intima-media thickening or coronary artery calcification. In recent trials, patients found to have coronary artery disease on computed tomography (CT) coronary angiography were more likely to be started on preventative therapy and had lower rates of cardiac events. This led to the design of the SCOT-HEART 2 (Scottish Computed Tomography of the Heart 2) trial, which aims to determine whether screening with the use of CT coronary angiography is more clinically effective than cardiovascular risk scoring to guide the use of primary preventative therapies and reduce the risk of myocardial infarction.</p></div>","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":"17 9","pages":"Pages 1101-1112"},"PeriodicalIF":12.8000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1936878X24002286/pdfft?md5=adafd7774de436b3bc937ef39c2d3fec&pid=1-s2.0-S1936878X24002286-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Rationale and Design of SCOT-HEART 2 Trial\",\"authors\":\"Michael McDermott MBChB , Mohammed N. Meah MBChB, PhD , Phyo Khaing MBChB , Kang-Ling Wang MD , Jennifer Ramsay MBChB , Gillian Scott PhD , Hannah Rickman MPH , Tom Burt , Ian McGowan , Timothy Fairbairn MBChB, PhD , Marise Bucukoglu , Russell Bull MBBChir , Adam Timmis MBChB, PhD , Edwin J.R. van Beek MD, PhD , Giles Roditi MBChB , Philip D. Adamson MBChB, PhD, MPH , Steff Lewis MSC, PhD , John Norrie MSc , Brian McKinstry MBChB, MD , Bruce Guthrie MBChB, PhD , David E. Newby MBChB, PhD\",\"doi\":\"10.1016/j.jcmg.2024.05.016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Coronary artery disease continues to be the leading cause of death globally. Identifying patients who are at risk of coronary artery disease remains a public health priority. At present, the focus of cardiovascular disease prevention relies heavily on probabilistic risk scoring despite no randomized controlled trials demonstrating their efficacy. The concept of using imaging to guide preventative therapy is not new, but has previously focused on indirect measures such as carotid intima-media thickening or coronary artery calcification. In recent trials, patients found to have coronary artery disease on computed tomography (CT) coronary angiography were more likely to be started on preventative therapy and had lower rates of cardiac events. This led to the design of the SCOT-HEART 2 (Scottish Computed Tomography of the Heart 2) trial, which aims to determine whether screening with the use of CT coronary angiography is more clinically effective than cardiovascular risk scoring to guide the use of primary preventative therapies and reduce the risk of myocardial infarction.</p></div>\",\"PeriodicalId\":14767,\"journal\":{\"name\":\"JACC. Cardiovascular imaging\",\"volume\":\"17 9\",\"pages\":\"Pages 1101-1112\"},\"PeriodicalIF\":12.8000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1936878X24002286/pdfft?md5=adafd7774de436b3bc937ef39c2d3fec&pid=1-s2.0-S1936878X24002286-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC. Cardiovascular imaging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1936878X24002286\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Cardiovascular imaging","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1936878X24002286","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Coronary artery disease continues to be the leading cause of death globally. Identifying patients who are at risk of coronary artery disease remains a public health priority. At present, the focus of cardiovascular disease prevention relies heavily on probabilistic risk scoring despite no randomized controlled trials demonstrating their efficacy. The concept of using imaging to guide preventative therapy is not new, but has previously focused on indirect measures such as carotid intima-media thickening or coronary artery calcification. In recent trials, patients found to have coronary artery disease on computed tomography (CT) coronary angiography were more likely to be started on preventative therapy and had lower rates of cardiac events. This led to the design of the SCOT-HEART 2 (Scottish Computed Tomography of the Heart 2) trial, which aims to determine whether screening with the use of CT coronary angiography is more clinically effective than cardiovascular risk scoring to guide the use of primary preventative therapies and reduce the risk of myocardial infarction.
期刊介绍：
JACC: Cardiovascular Imaging, part of the prestigious Journal of the American College of Cardiology (JACC) family, offers readers a comprehensive perspective on all aspects of cardiovascular imaging. This specialist journal covers original clinical research on both non-invasive and invasive imaging techniques, including echocardiography, CT, CMR, nuclear, optical imaging, and cine-angiography.
JACC. Cardiovascular imaging highlights advances in basic science and molecular imaging that are expected to significantly impact clinical practice in the next decade. This influence encompasses improvements in diagnostic performance, enhanced understanding of the pathogenetic basis of diseases, and advancements in therapy.
In addition to cutting-edge research,the content of JACC: Cardiovascular Imaging emphasizes practical aspects for the practicing cardiologist, including advocacy and practice management.The journal also features state-of-the-art reviews, ensuring a well-rounded and insightful resource for professionals in the field of cardiovascular imaging.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
